##Beta blocker reduces lung inflammation in critical COVID-19 | Golden pharma

##Beta blocker reduces lung inflammation in critical COVID-19 patients##

As indicated in the journal of the American College of Cardiology, administration of IV metoprolol to COVID-19 patients with ARDS reduced lung inflammation associated with the disease

Metoprolol administration also resulted in better oxygenation and fewer days on mechanical ventilation and in the ICU

@Ethiomedicalconsultancy
#Join#us#for#more
Medical videos,
Scientific tips,
Medical books,
Medical journals and
Interesting case discussions

@EthioMedicalConsultancy